/ Not yet recruitingPhase 2 A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE
100 Clinical Results associated with Advantage Therapeutics GmbH
0 Patents (Medical) associated with Advantage Therapeutics GmbH
100 Deals associated with Advantage Therapeutics GmbH
100 Translational Medicine associated with Advantage Therapeutics GmbH